4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-17-000067
CIK 0000899866operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:03 PM ET
Size
5.1 KB
Accession
0000899866-17-000067
Insider Transaction Report
Form 4
Thiel Carsten
SVP, EMEA & Asia Pacific
Transactions
- Sale
Common Stock, par value $.0001 per share
2017-02-28$131.01/sh−3,783$495,611→ 33,860 total
Footnotes (2)
- [F1]The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $130.70 - $131.69. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:03 PM ET
- Size
- 5.1 KB